This review discusses the impacts of antibiotic resistance and biofilm formation on treatment, suggesting new therapeutic strategies for infective endocarditis.
Key Points
The mortality rate of infective endocarditis is high, highlighting the urgency for effective treatments.
Antibiotic resistance and biofilm formation complicate the management of infective endocarditis, necessitating improved therapeutic strategies.
Current guidelines advocate for early empirical antibiotic therapy, adjusted based on microbial sensitivity tests.
Integrating improved diagnostics and new therapies may enhance survival rates and reduce complications in infective endocarditis patients.